Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06850870 · ClinicalTrials.gov registry record · Phase 1
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
A Phase 1 study of Dementia and Cognitive Decline, sponsored by Onward Health.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06850870: Recruiting Phase 1 study of Dementia and Cognitive Decline, sponsored by Onward Health.
NCT06850870 is a Phase 1 study of Dementia and Cognitive Decline that is actively recruiting participants, run by Onward Health. The registered enrollment target is 120 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06850870, a Phase 1 study of Dementia and Cognitive Decline, is actively recruiting participants, sponsored by Onward Health.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot randomized controlled trial is to assess the impact of D2D rideshare services with a trained companion driver on the rate of medical appointments for older adults and individuals with AD/ADRD. Participants will be assigned either door-through-door (D2D) rideshare or curb-to-curb (C2C) rideshare services. he main question it aims to answer is: Do D2D rideshare services reduce missed medical appointment rates compared to C2C rideshare services?
Primary Outcome
The rate of missed medical appointments (No shows and same day cancellations).
Conditions Studied
Interventions
- OTHER Door-through-door companion rideshare
- OTHER Curb-to-curb rideshare services
Study Locations (1)
California
- Onward Health HQ - San Leandro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-08-29 |
| Est. Completion | 2026-11-28 |
| Phase | Phase 1 |
What NCT06850870 shows while recruiting
NCT06850870 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Dementia appearing as the primary indexed condition, and to 2 interventions - of which Door-through-door companion rideshare is the first listed.
NCT06850870 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06850870 about?
NCT06850870 is a clinical study titled "Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)". The goal of this pilot randomized controlled trial is to assess the impact of D2D rideshare services with a trained companion driver on the rate of medical appointments for older adults and individuals with AD/ADRD. Participants will be assigned either door-through-door (D2D) rideshare or curb-to-cu...
What is the current status of trial NCT06850870?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 120 participants. The study started on 2025-08-29. Estimated completion is 2026-11-28.
What conditions does trial NCT06850870 study?
This clinical trial studies the following conditions: Dementia, Cognitive Decline, Alzheimer Disease or Associated Disorder.
What interventions are being tested in trial NCT06850870?
The interventions under investigation include: Door-through-door companion rideshare (OTHER), Curb-to-curb rideshare services (OTHER).
Who is sponsoring clinical trial NCT06850870?
This trial is sponsored by Onward Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06850870 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06850870's enrollment target sits among peer trials
120 108th of 199 higher than 88 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ferritin and Iron Burden in SAH sIRB
RECRUITING · Phase 1
-
Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer
RECRUITING · Phase 1
-
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
RECRUITING · Phase 1
-
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
RECRUITING · Phase 1
-
Sirtuin-NAD Activator in Alzheimer's Disease
ACTIVE NOT RECRUITING · Phase 1
-
Home Safety Clinical Trial for Alzheimer's Disease
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI